{"gao_id": "GAO-17-231", "published": "2017-02-07T12:00:00Z", "released": "2017-02-08T07:00:00Z", "summary": "In 1991, FDA allowed the first laparoscopic power morcellator\u2014a device that cuts tissue into small pieces, which can be removed during minimally invasive surgeries\u2014on the U.S. market. In late 2013, the agency began to receive reports that these devices may spread a difficult-to-diagnose cancer when used to treat uterine fibroids. In April 2014, FDA estimated that the risk of having the type of uterine cancer...", "title": "Medical Devices: Cancer Risk Led FDA to Warn Against Certain Uses of Power Morcellators and Recommend New Labeling", "topics": ["Physicians", "Cancer research", "Health Care", "Inspection", "Documentation", "Hospitals", "Cancer", "Risk assessment", "Medical equipment", "Medical information systems", "Monitoring", "Women", "Health care facilities", "Risk management", "Information technology"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-17-231", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-17-231-highlights.pdf"}, {"title": "Full Report (49 pages)", "url": "https://www.gao.gov/assets/gao-17-231.pdf"}, {"title": "Accessible PDF (54 pages)", "url": "https://www.gao.gov/assets/690/683277.pdf"}]}